The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Tuomo Nieminen

Harvard Medical School

Beth Israel Deaconess Medical Center

Boston

Massachusetts 02215

USA

[email]@iki.fi

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. 2010
  • Department of Pharmacological Sciences, Medical School, University of Tampere, Tampere, Finland. 2005 - 2008

References

  1. Atrioventricular conduction and cardiovascular mortality: assessment of recovery PR interval is superior to pre-exercise measurement. Nieminen, T., Verrier, R.L., Leino, J., Nikus, K., Lehtinen, R., Lehtimäki, T., Minkkinen, M., Kööbi, T., Turjanmaa, V., Viik, J., Kähönen, M. Heart. Rhythm (2010) [Pubmed]
  2. Pattern of crescendo TWA may disclose the underlying cardiac pathology. Nieminen, T., Verrier, R.L., Nikus, K., Viik, J., Lehtinen, R., Lehtimäki, T., Kaiser, W., Kähönen, M. J. Electrocardiol (2010) [Pubmed]
  3. The prognostic value of haemodynamic parameters in the recovery phase of an exercise test. The Finnish Cardiovascular Study. Nieminen, T., Leino, J., Maanoja, J., Nikus, K., Viik, J., Lehtimäki, T., Kööbi, T., Lehtinen, R., Niemelä, K., Turjanmaa, V., Kähönen, M. J. Hum. Hypertens (2008) [Pubmed]
  4. Degradative and mechanical properties of a novel resorbable plating system during a 3-year follow-up in vivo and in vitro. Nieminen, T., Rantala, I., Hiidenheimo, I., Keränen, J., Kainulainen, H., Wuolijoki, E., Kallela, I. J. Mater. Sci. Mater. Med (2008) [Pubmed]
  5. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. Nieminen, T., Kähönen, M., Viiri, L.E., Grönroos, P., Lehtimäki, T. Pharmacogenomics (2008) [Pubmed]
  6. Amorphous and crystalline polyetheretherketone: Mechanical properties and tissue reactions during a 3-year follow-up. Nieminen, T., Kallela, I., Wuolijoki, E., Kainulainen, H., Hiidenheimo, I., Rantala, I. J. Biomed. Mater. Res. A (2008) [Pubmed]
  7. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the Cardiovascular Risk in Young Finns study. Nieminen, T., Kähönen, M., Islam, S., Raitakari, O.T., Hutri-Kähönen, N., Marniemi, J., Juonala, M., Rontu, R., Viikari, J., Lehtimäki, T. Circ. J. (2007) [Pubmed]
  8. Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variation in young men during pravastatin therapy. Nieminen, T., Knuuti, J., Hämelahti, P., Kähönen, M., Laaksonen, R., Janatuinen, T., Vesalainen, R., Nuutila, P., Jokela, H., Lehtimäki, T. Vascul. Pharmacol. (2007) [Pubmed]
  9. The relationship of sterol regulatory element-binding protein cleavage-activation protein and apolipoprotein E gene polymorphisms with metabolic changes during weight reduction. Nieminen, T., Matinheikki, J., Nenonen, A., Kukkonen-Harjula, K., Lindi, V., Hämelahti, P., Laaksonen, R., Fan, Y.M., Kähönen, M., Fogelholm, M., Lehtimäki, T. Metab. Clin. Exp. (2007) [Pubmed]
  10. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Nieminen, T., Lehtimäki, T., Mäenpää, J., Ropo, A., Uusitalo, H., Kähönen, M. Scand. J. Clin. Lab. Invest. (2007) [Pubmed]
  11. In vivo and in vitro degradation of a novel bioactive guided tissue regeneration membrane. Nieminen, T., Kallela, I., Keränen, J., Hiidenheimo, I., Kainulainen, H., Wuolijoki, E., Rantala, I. Int. J. Oral. Maxillofac. Surg (2006) [Pubmed]
  12. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study. Nieminen, T., Lehtimäki, T., Laiho, J., Rontu, R., Niemelä, K., Kööbi, T., Lehtinen, R., Viik, J., Turjanmaa, V., Kähönen, M. J. Appl. Physiol. (2006) [Pubmed]
  13. The Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality. Nieminen, T., Lehtinen, R., Viik, J., Lehtimäki, T., Niemelä, K., Nikus, K., Niemi, M., Kallio, J., Kööbi, T., Turjanmaa, V., Kähönen, M. BMC. Cardiovasc. Disord (2006) [Pubmed]
  14. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement. Nieminen, T., Tammela, T.L., Kööbi, T., Kähönen, M. J. Urol. (2006) [Pubmed]
  15. Hypotensive potential of sildenafil and tamsulosin during orthostasis. Nieminen, T., Kööbi, T., Tammela, T.L., Kähönen, M. Clin. Drug. Investig (2006) [Pubmed]
  16. The effects of apoA-I/C-III/A-IV, apoE and apoB polymorphisms on carotid artery intima-media thickness. Nieminen, T., Kähönen, M., Lehtimäki, T. Future. Cardiol (2006) [Pubmed]
  17. The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo-controlled study. Nieminen, T., Ylitalo, R., Kööbi, T., Ylitalo, P., Kähönen, M. Eur. Urol. (2005) [Pubmed]
  18. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study. Nieminen, T., Ylitalo, R., Kööbi, T., Ylitalo, P., Kähönen, M. Arzneimittelforschung (2005) [Pubmed]
  19. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients. Nieminen, T., Uusitalo, H., Turjanmaa, V., Bjärnhall, G., Hedenström, H., Mäenpää, J., Ropo, A., Heikkilä, P., Kähönen, M. Eur. J. Clin. Pharmacol. (2005) [Pubmed]
  20. Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study. Nieminen, T., Uusitalo, H., Mäenpää, J., Turjanmaa, V., Rane, A., Lundgren, S., Ropo, A., Rontu, R., Lehtimäki, T., Kähönen, M. Eur. J. Clin. Pharmacol. (2005) [Pubmed]
 
WikiGenes - Universities